Health
Chronicle Pharmabiz
Panel asks MoA to intensify efforts to clear pending UCs
RAISING concerns over the insufficient level of liquidation of Utilisation Certificates (UCs) related to the schemes under the Ministry of Ayush, the Parliamentary Panel on Health and Family Welfare has urged the Ministry to intensify efforts to expedite the clearance of pending UCs, particularly under the National Ayush Mission (NAM).
3 min |
January 15, 2026
Chronicle Pharmabiz
Comm Min launches MAS under EPM-NIRYAT DISHA to boost exports
THE Union ministry of commerce has launched Market Access Support (MAS) intervention under the Export Promotion Mission (EPM)-NIRYAT DISHA with immediate effect towards strengthening India's export market access.
2 min |
January 15, 2026
Chronicle Pharmabiz
Novartis to build its 4th US radioligand therapy mfg unit in Winter Park
NOVARTIS, a leading global innovative medicines company, announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida.
1 min |
January 15, 2026
Chronicle Pharmabiz
'MSMEs need handholding to implement e-submission of WHO-GMP CoPP'
PHARMA MSMEs need assistance to implement Central Drugs Standard Control Organisation (CDSCO)'s mandate of applying online for World Health Organization-Good Manufacturing Practices (WHO-GMP) Certificate of Pharmaceutical Product (CoPP), according to the BDMAI president A P Rameswara Rao.
1 min |
January 15, 2026
Chronicle Pharmabiz
'Separate licensing for bulk drugs to plug regulatory gap in supply'
THE Union health ministry's proposal to revamp work for bulk drugs, active pharmaceutical ingredients (APIs) and key starting materials (KSMs) will plug regulatory gap in the supply chain, according to Harish Jain, national president, Federation of Pharma Entrepreneurs (FOPE).
2 min |
January 15, 2026
Chronicle Pharmabiz
Practo launches care navigation platform in US
PRACTO, one of the world's most trusted digital healthcare platforms, announced the launch of its care navigation platform in the United States, marking its most significant international expansion following a strong debut in the UAE in the year 2025.
1 min |
January 15, 2026
Chronicle Pharmabiz
PAI Pharma acquires Nivagen Pharmaceuticals
PAI Pharma, US-based pharmaceutical manufacturer specializing in oral liquid generic prescription medications with strong domestic manufacturing footprint and a commitment to quality, affordability, and supply chain resilience, and Olympus Partners, a leading US developer, manufacturer and marketer of oral liquid medicines, announced the acquisition of Nivagen Pharmaceuticals, Inc. (Nivagen), a California-based pharmaceutical company with advanced aseptic manufacturing infrastructure and a robust pipeline of ready-to-use sterile injectables.
1 min |
January 15, 2026
Chronicle Pharmabiz
Allegations of electoral fraud, malpractice in APPC election
THE Andhra Pradesh Pharmacy Council (APPC) election, conducted in December 2025, has now become a major legal and administrative crisis following an emergency complaint filed with the state's chief secretary.
1 min |
January 15, 2026
Chronicle Pharmabiz
Medanta launches 'Socho Mat Baat Karo' campaign
MEDANTA, The Medicity, one of India's leading super-speciality hospitals, has launched its community-focused prostate cancer awareness initiative, 'Socho Mat Baat Karo' (SMBK).
2 min |
January 15, 2026
Chronicle Pharmabiz
Indian pharma eyes prospects with needle-free drug delivery
NEEDLE-free drug delivery is moving from a promising innovation to an expected standard. As patients look for comfort, ease of use, and more control over their treatments, the appetite for needle-free options has surged.
1 min |
January 15, 2026
Chronicle Pharmabiz
BDCDA seeks reconsideration of K'taka D&C Rules amendments
THE Bangalore District Chemists and Druggists Association (BDCDA) has called for reconsideration and appropriate inclusion of certain rules in the amendments to Rules under the Drugs and Cosmetics Act (Karnataka Amendment) Act, 2025. This bill was presented in December 2025 at Legislature session at Belagavi by Karnataka health & family welfare minister, Dinesh Gundu Rao.
2 min |
January 15, 2026
Chronicle Pharmabiz
India's herbal, Ayurveda prioritize clean labels to strengthen trust
INDIA's herbal and Ayurveda sector is increasingly transparency prioritizing and clean labelling to build consumer trust and reinforce the integrity of its products.
2 min |
January 15, 2026
Chronicle Pharmabiz
Pondicherry DC mandates 100% batch testing to combat counterfeit drugs
FOLLOWING the recent exposure of a massive multi-state counterfeit medicine racket that has been referred to the CBI and NIA, the Pondicherry Department of Drugs Control has launched an aggressive regulatory cleansing of the pharmaceutical sector to restore public trust and safety.
1 min |
January 15, 2026
Chronicle Pharmabiz
Telangana DCA seizes illegal drugs from practitioner
THE Drugs Control Administration (DCA) of Telangana conducted a strategic raid targeting an illegal medical practice in Vidya Nagar in Karimnagar.
1 min |
January 15, 2026
Chronicle Pharmabiz
India's vision health signals shift with innovation in cataract surgery
INDIA's eye care landscape is witnessing a significant paradigm shift driven by precision innovations in cataract surgery and the advent of specialized defocus lenses for myopia management.
2 min |
January 15, 2026
Chronicle Pharmabiz
AHPI calls for adoption of 'CIBIL-like' framework
THE West UP Chapter of the Association of Healthcare Providers India (AHPI) has called for the establishment of a 'CIBIL-like' rating framework for insurers and Third Party Administrators (TPAs) to bring transparency and accountability in the healthcare sector.
1 min |
January 15, 2026
Chronicle Pharmabiz
Yoga can speed up recovery from opioid withdrawal symptoms: Study
THE National Institute of Mental Health and Neuro Sciences (NIMHANS) Centre for Addiction Medicine has found that Yoga can dramatically speed up recovery from opioid withdrawal symptoms by cutting recovery time nearly by half.
2 min |
January 15, 2026
Chronicle Pharmabiz
UK MHRA approves Ogsiveo to treat desmoid tumours
THE UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in adults.
1 min |
January 15, 2026
Chronicle Pharmabiz
India needs review of labelling requirements for medicines
INDIA needs a comprehensive review of labelling requirements for drugs, foods, and Ayush medicines to ensure clarity, consistency, and consumer safety across regulated products, said D B Anantha Narayana, CSO, Ayurvidye Trust.
2 min |
January 15, 2026
Chronicle Pharmabiz
MTaI seeks govt to align med-tech customs, GST structures
THE Medical Technology Association of India (May), the sociation of India (MTal), the association of research-based medical technology companies with global experience in innovation and manufacturing in India, has said that the Central government should align the medtech customs and Goods and Services Tax (GST) structures with other priority sectors to support domestic manufacturing of medical devices.
1 min |
January 15, 2026
Chronicle Pharmabiz
DoP calls for proposals to set up common facilities for device clusters
THE Department of Pharmaceuticals (DOP) has invited applications from eligible stakeholders to set up common facilities for medical device clusters in the country, under the scheme for Strengthening of Medical Device Industry (SMDI).
2 min |
January 15, 2026
Chronicle Pharmabiz
India bolsters medical transportation with technology
INDIA is strengthening its medical transportation system for chronic care patients through strategic integration of technology. With advanced tracking systems, telemedicine support, and real-time route optimization, hospitals and healthcare providers are working to ensure safer, faster, and more reliable patient travel. This technology-driven approach aims to reduce delays, improve coordination, and enhance the overall quality of care for patients who require frequent medical attention.
1 min |
January 15, 2026
Chronicle Pharmabiz
DCGI releases classification of 77 medical devices related to oncology
As part of its efforts to regulate the medical devices in the country, the Drugs Controller General (India) has issued a notice classifying 77 medical devices pertaining to oncology under the provisions of Medical Devices Rules (MDR), 2017.
2 min |
January 15, 2026
Chronicle Pharmabiz
Bulk drugs, intermediates imports decline 2.8% in Nov
IMPORTS of bulk drugs and intermediates to India registered a decline of 2.81% in the month of November, 2025, while exports grew 11% during the month as compared to the same period of previous year.
1 min |
January 15, 2026
Chronicle Pharmabiz
How technology advancements can help alleviate myopia rise
MYOPIA is a widespread vision issue affecting over two billion individuals across the globe and it at present growing public health challenge. With an estimated 161 million people experiencing blindness or moderate-to-severe vision loss from uncorrected refractive errors in 2020 and it has become a leading cause of vision impairment.
3 min |
January 15, 2026
Chronicle Pharmabiz
DGFT amends norms for exporting metformin HCL
Our Bureau, Mumbai HE Directorate General of Foreign Trade (DGFT) has notified amendments in measurement for key inputs or import items under standard input output norms (SION) A-290 for exporting active pharmaceutical ingredient (API) metformin hydrochloride (HCL).
1 min |
January 15, 2026
Chronicle Pharmabiz
BioAsia 2026 to be held from Feb 16 to 18 in Hyderabad
BIOASIA 2026, the 23rd edition of Asia’s premier life sciences and health-technology forum, was released by Telangana minister for IT, electronics & communications, and industries & commerce, D Sridhar Babu.
1 min |
January 15, 2026
Chronicle Pharmabiz
Telangana DCA busts unlicensed medical device unit in Sangareddy
IN a major enforcement action, the DCA of Telangana busted an unlicensed medical device manufacturing facility in Sangareddy District on December 23, 2025.
1 min |
January 1, 2026
Chronicle Pharmabiz
Motilal Oswal invests US$ 72 mn in Sensa Core
MOTILAL Oswal Alternates had Monde Oswal AlternatES made a significant minority investment of US$ 72 million in Sensa Core, an innovation-driven medical devices' company focused on advancing healthcare technology in India.
1 min |
January 1, 2026
Chronicle Pharmabiz
Odisha announces Pharma, Med Devices Policy 2025
MARKING a historic shift in the state's industrial landscape, chief minister Mohan Charan Majhi has officially unveiled the Odisha Pharmaceutical and Medical Devices Policy 2025 at the inaugural Odisha Pharma Summit in Bhubaneswar on December 16.
1 min |